Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grimaldi

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Oncotarget|March 20, 2018
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Francesco Spagnolo, Virginia Picasso, et al.
Breast (Edinburgh, Scotland)|March 31, 2023
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patientsDamiano Gentile, Andrea Sagona, Camilla De Carlo, et al.
Trials|August 29, 2013
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trialImmacolata Capasso, Emanuela Esposito, Nicola Maurea, et al.
Diabetology & Metabolic Syndrome|October 7, 2014
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtypeImmacolata Capasso, Emanuela Esposito, Michelino de Laurentiis, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2013
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experienceImmacolata Capasso, Emanuela Esposito, Francesca Pentimalli, et al.
The British Journal of Surgery|July 20, 2023
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, et al.
Oxidative Medicine and Cellular Longevity|March 16, 2016
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric CarcinogenesisAldo Giudice, Giovanni D'Arena, Anna Crispo, et al.
BMC Health Services Research|November 27, 2020
Clinical trials and drug cost savings for Italian health serviceFrancesca D'Ambrosio, Gianfranco De Feo, Gerardo Botti, et al.
Cancer Biology & Therapy|October 12, 2010
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experienceImmacolata Capasso, Emanuela Esposito, Francesca Pentimalli, et al.
Cancers|June 2, 2021
The Ratio of GrzB<sup>+</sup> - FoxP3<sup>+</sup> over CD3<sup>+</sup> T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Oncotarget|March 20, 2018
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Francesco Spagnolo, Virginia Picasso, et al.
Breast (Edinburgh, Scotland)|March 31, 2023
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patientsDamiano Gentile, Andrea Sagona, Camilla De Carlo, et al.
Trials|August 29, 2013
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trialImmacolata Capasso, Emanuela Esposito, Nicola Maurea, et al.
Diabetology & Metabolic Syndrome|October 7, 2014
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtypeImmacolata Capasso, Emanuela Esposito, Michelino de Laurentiis, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2013
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experienceImmacolata Capasso, Emanuela Esposito, Francesca Pentimalli, et al.
The British Journal of Surgery|July 20, 2023
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, et al.
Oxidative Medicine and Cellular Longevity|March 16, 2016
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric CarcinogenesisAldo Giudice, Giovanni D'Arena, Anna Crispo, et al.
BMC Health Services Research|November 27, 2020
Clinical trials and drug cost savings for Italian health serviceFrancesca D'Ambrosio, Gianfranco De Feo, Gerardo Botti, et al.
Cancer Biology & Therapy|October 12, 2010
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experienceImmacolata Capasso, Emanuela Esposito, Francesca Pentimalli, et al.
Cancers|June 2, 2021
The Ratio of GrzB<sup>+</sup> - FoxP3<sup>+</sup> over CD3<sup>+</sup> T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.
Pageof 16